Validation of a registry-derived risk algorithm based on treatment protocol as a proxy for disease risk in childhood acute lymphoblastic leukemia.
about
Validation of a registry-derived risk algorithm based on treatment protocol as a proxy for disease risk in childhood acute lymphoblastic leukemia.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Validation of a registry-deriv ...... acute lymphoblastic leukemia.
@ast
Validation of a registry-deriv ...... acute lymphoblastic leukemia.
@en
Validation of a registry-deriv ...... acute lymphoblastic leukemia.
@nl
type
label
Validation of a registry-deriv ...... acute lymphoblastic leukemia.
@ast
Validation of a registry-deriv ...... acute lymphoblastic leukemia.
@en
Validation of a registry-deriv ...... acute lymphoblastic leukemia.
@nl
prefLabel
Validation of a registry-deriv ...... acute lymphoblastic leukemia.
@ast
Validation of a registry-deriv ...... acute lymphoblastic leukemia.
@en
Validation of a registry-deriv ...... acute lymphoblastic leukemia.
@nl
P2860
P356
P1476
Validation of a registry-deriv ...... d acute lymphoblastic leukemia
@en
P2093
Astrid Guttmann
Lillian Sung
P2860
P2888
P356
10.1186/1471-2288-13-68
P577
2013-05-30T00:00:00Z
P5875
P6179
1039766426